首页> 美国卫生研究院文献>Cancer Science >Quantification of Epstein–Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China
【2h】

Quantification of Epstein–Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China

机译:鼻咽刷检样本中爱泼斯坦-巴尔病毒DNA含量的定量分析在中国南方鼻咽癌中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nasopharyngeal carcinoma (NPC) is highly incident in southern China, where 40% of world's new cases arise each year. Detection of Epstein–Barr virus (EBV) DNA load in nasopharyngeal (NP) brush/swab samples has gradually been established as a method for diagnosis of NPC. However, its applicable value in NPC diagnosis has never been investigated in southern China. It is important to explore whether such a test could be applicable to our local population. A total of 245 consecutive participants undergoing NP brushing examination were recruited to obtain the NP brushing samples in this study. Quantitative PCR assays were used to obtain the EBV DNA load. Mann–Whitney, ANOVA and receiver operating characteristic tests were used to analyze its diagnostic value. NP brushing samples from NPC patients showed extremely high levels of EBV DNA load (mean = 46360 copyg DNA) compared to its expression from non-NPC control (mean = 28 copyg DNA) and high-risk control (mean = 50 copyg DNA) groups. It produced 96% sensitivity and 97% specificity, at the COV = 225 copyg DNA. Furthermore, EBV DNA load could reflect disease progress. Our data showed a better performance of EBV DNA load in NP brushing samples compared with an initial biopsy, immunoglobulin A (IgA) antibody titers to viral capsid antigen in serum and EBV DNA load in plasma. Detection of EBV DNA load in NP brushing samples could be an effective supplement for NPC diagnosis. Being minimally invasive and low cost, NP brush sampling combined with EBV DNA detection demonstrates great potential for screening high-risk populations for NPC.
机译:鼻咽癌(NPC)在中国南部非常普遍,每年全世界有40%的新病例出现。鼻咽(NP)刷/拭子样本中爱泼斯坦-巴尔病毒(EBV)DNA含量的检测已逐步建立,作为诊断NPC的方法。但是,其在全国人大诊断中的应用价值尚未在中国南方进行过调查。重要的是要探索这种测试是否适用于我们当地的人口。本研究共招募了245位连续进行NP刷牙检查的参与者,以获取NP刷牙样品。定量PCR测定用于获得EBV DNA负载。使用Mann-Whitney,ANOVA和接收器工作特性测试来分析其诊断价值。与非NPC对照(平均值= 28拷贝/ ng DNA)和高风险对照(平均值= 50)的表达相比,来自NPC患者的NP刷洗样本显示出极高水平的EBV DNA负载(平均值= 46360复制/ ng DNA)复制/ ng DNA)组。它在COV = 225复制/ ng DNA时产生96%的灵敏度和97%的特异性。此外,EBV DNA负载可能反映疾病进展。我们的数据显示,与最初的活检,对血清中病毒衣壳抗原的免疫球蛋白A(IgA)抗体滴度和血浆中EBV DNA载量相比,NP刷洗样品中EBV DNA载量的性能更好。检测NP刷洗样本中的EBV DNA量可能是NPC诊断的有效补充。 NP刷采样与EBV DNA检测相结合,具有最低的侵入性和低成本,显示出筛查高危人群NPC的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号